Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-3.2%
5Y CAGR-42.6%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-3.2%/yr
vs -92.8%/yr prior
5Y CAGR
-42.6%/yr
Recent acceleration
Acceleration
+89.6pp
Accelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.41 | -44.4% |
| 2024 | 9.74 | -29.5% |
| 2023 | 13.80 | +131.5% |
| 2022 | 5.96 | -89.5% |
| 2021 | 57.00 | -34.2% |
| 2020 | 86.66 | - |
| 2019 | 0.00 | -100.0% |
| 2018 | 221193.86 | +30410.7% |
| 2017 | 724.97 | +154.0% |
| 2016 | 285.46 | - |